Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Acute Myocarditis Related to COVID-19: Comparison to SARS and MERS
Angeliki M Chasouraki1, Odyssefs A Violetis1, Mahmoud Abdelrasoul1
1Internal Medicine Clinic, Pammakaristos Hospital of Divine Providence (Reference Centre for COVID-19 infection), Iakovaton 43, 11144 Athens, Greece.
Abstract:
Myocardial involvement has been described during previous SARS and MERS outbreaks. Infection by SARS-CoV-2 (COVID-19) can range from asymptomatic to life-threatening multi-system disease. Heart involvement most commonly occurs during severe COVID-19 infection. Myocardial injury, based on elevated levels of myocardial enzymes, has been noted in up to 30% of patients with COVID-19 infection and could be a marker for worse prognosis. A few cases of possible myocarditis due to SARS-CoV-2 have been described, providing variable degree of evidence of direct myocardial involvement. We reviewed in detail those cases in comparison to relevant literature on SARS and MERS and attempted to draw initial conclusions in regard to clinical presentation, treatment and prognosis.
Insights
Severe COVID-19 infection can impact the heart, with myocardial injury observed in up to 30% of patients. This review examines potential myocarditis cases linked to SARS-CoV-2, comparing them with prior coronavirus outbreaks.
Area of Science:
- Cardiology
- Infectious Diseases
- Virology
Background:
- Previous outbreaks of SARS and MERS demonstrated myocardial involvement.
- SARS-CoV-2 (COVID-19) infection presents a spectrum of severity, from asymptomatic to critical multi-system disease.
- Cardiac complications, particularly myocardial injury, are increasingly recognized in severe COVID-19.
Purpose of the Study:
- To review and analyze reported cases of myocarditis associated with SARS-CoV-2 infection.
- To compare the clinical presentation, treatment, and prognosis of COVID-19-related myocarditis with findings from SARS and MERS outbreaks.
- To assess the evidence for direct myocardial involvement in SARS-CoV-2 infection.
Main Methods:
- Literature review of cases describing myocarditis in COVID-19 patients.
- Comparative analysis with existing literature on myocardial involvement in SARS and MERS.
- Evaluation of clinical data, diagnostic markers (e.g., myocardial enzymes), and outcomes.
Main Results:
- Myocardial injury, indicated by elevated cardiac enzymes, affects up to 30% of COVID-19 patients, correlating with poorer prognosis.
- Evidence for direct SARS-CoV-2 myocardial involvement in myocarditis cases is variable.
- Comparison with SARS and MERS suggests potential similarities in cardiac manifestations.
Conclusions:
- Myocardial involvement is a significant concern in severe COVID-19.
- Further research is needed to elucidate the mechanisms and clinical implications of SARS-CoV-2-induced myocarditis.
- Understanding cardiac involvement in COVID-19 is crucial for patient management and prognosis, drawing parallels from previous coronavirus studies.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Endocarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests